The conference will bring together experts in upper airway microbiology with an emphasis in the nasal/sinus cavities, larynx and trachea to advance and integrate knowledge of the upper airway microbiome in health and disease.
This project will define the microbial processes and species responsible for oxidation of ferrous iron (where the iron ion shares two of its electrons) and consequent weathering of iron-containing mineral aggregates.
This project will help researchers understand how the susceptibility of a plant host affects its microbiome and identify ways that the plant microbiome can be measured and manipulated to improve food safety and agricultural sustainability.
The project will develop an effective set of computational and experimental tools that can quantify and predict the concentration and turnover rates of intracellular and extracellular metabolites (i.e. fluxes) in microbial communities.
This study, Examining the Potential of the Microbiome in Children to Reduce Antibiotic Resistance (EPIC) will examine the impact of daycare on a child’s microbiome and risk of infection with drug-resistant pathogens.
This project will create the Population-based Microbiome Research Core (PMRC) in the Survey of Health of Wisconsin (SHOW).
This project will examine ecological interactions and environmental factors that influence butyrate production in the gut microbiome.
This research will test whether Alzheimer’s disease is caused, or at least influenced, by the gut microbiome.
This project funds creation of a germ-free facility that will provide services for the whole UW-Madison community. It proposes a partnership with Laboratory Animal Research (LAR) within the School of Medicine and Public Health to build and manage a facility that meets the needs of the campus.
This project will fund development of a soil “Microbiotron” — a modular system of 48 soil-plant incubation chambers, each individually instrumented and controlled by a centralized system.
This project funds research to look at asymptomatic infection with the parasite Toxoplasma gondii, which occurs in about 33 percent of the world’s population (but used to occur in nearly 100 percent. Toxoplasma results in fat malabsorption and reduced weight gain irrespective of diet.
The Microbiome Hub will provide the means for researchers in diverse fields at UW-Madison, who have no training in microbiology or bioinformatics, to routinely examine the microbiome in their studies.
Comparing “germ free” and colonized mice on defined diets, this project will explore how gut microbes alter the levels of circulating metabolites, specifically essential nutrient choline, and how these dynamic metabolites alter the host’s epigenome.